Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,701 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Survival of multiple myeloma patients aged 65-70 years in the era of novel agents and autologous stem cell transplantation. A multicenter retrospective collaborative study of the Japanese Society of Myeloma and the European Myeloma Network.
Ozaki S, Harada T, Saitoh T, Shimazaki C, Itagaki M, Asaoku H, Kuroda Y, Chou T, Yoshiki Y, Suzuki K, Murakami H, Hayashi K, Mina R, Palumbo A, Shimizu K; Japanese Society of Myeloma; European Myeloma Network. Ozaki S, et al. Among authors: hayashi k. Acta Haematol. 2014;132(2):211-9. doi: 10.1159/000357394. Acta Haematol. 2014. PMID: 24662986 Free article.
High-dose chemotherapy and autologous peripheral blood stem cell transplantation in high-risk multiple myeloma.
Murakami H, Fujii H, Inaba T, Shimazaki C, Okamoto S, Miwa A, Sawamura M, Abe M, Chou T, Asaoku H, Kitahara Y, Hayashi K, Kosaka M, Togawa A, Takatsuki K; Japan Myeloma Study Group. Murakami H, et al. Among authors: hayashi k. Eur J Haematol. 2004 Sep;73(3):169-73. doi: 10.1111/j.1600-0609.2004.00282.x. Eur J Haematol. 2004. PMID: 15287913 Clinical Trial.
IDO2 rs10109853 polymorphism affects the susceptibility to multiple myeloma.
Kasamatsu T, Hashimoto N, Sakaya N, Awata-Shiraiwa M, Ishihara R, Murakami Y, Masuda Y, Gotoh N, Nagai K, Oda T, Yokohama A, Saitoh T, Handa H, Tsukamoto N, Hayashi K, Murakami H. Kasamatsu T, et al. Among authors: hayashi k. Clin Exp Med. 2021 May;21(2):323-329. doi: 10.1007/s10238-020-00681-w. Epub 2021 Mar 12. Clin Exp Med. 2021. PMID: 33709342
Author Correction: Predicting exacerbation of renal function by DNA methylation clock and DNA damage of urinary shedding cells: a pilot study.
Hishikawa A, Nishimura ES, Yoshimoto N, Nakamichi R, Hama EY, Ito W, Maruki T, Nagashima K, Shimizu-Hirota R, Takaishi H, Itoh H, Hayashi K. Hishikawa A, et al. Among authors: hayashi k. Sci Rep. 2024 Dec 31;14(1):32157. doi: 10.1038/s41598-024-84241-2. Sci Rep. 2024. PMID: 39741164 Free PMC article. No abstract available.
The Combination of Tumor-targeting Salmonella typhimurium A1-R Plus the Autophagy-inhibitor Chloroquine Synergistically Eradicates HT1080 Fibrosarcoma Cells In Vitro and In Vivo.
Morinaga S, Zhao M, Mizuta K, Kang BM, Bouvet M, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Tsuchiya H, Demura S, Hoffman RM. Morinaga S, et al. Among authors: hayashi k. In Vivo. 2025 Jan-Feb;39(1):102-109. doi: 10.21873/invivo.13807. In Vivo. 2025. PMID: 39740880
Wood-Derived Hydrogels for Osteochondral Defect Repair.
Hayashi K, Tokumaru T, Shibahara K, Taleb Alashkar AN, Zhang C, Kishida R, Nakashima Y, Ishikawa K. Hayashi K, et al. ACS Nano. 2024 Dec 27. doi: 10.1021/acsnano.4c10430. Online ahead of print. ACS Nano. 2024. PMID: 39730305
8,701 results